JACC. Cardiovascular interventions, 2009-09, Vol.2 (9), p.855-860
- Lichtenwalter, Christopher, MD
- de Lemos, James A., MD
- Roesle, Michele, RN
- Obel, Owen, MD
- Holper, Elizabeth M., MD
- Haagen, Donald, RCIS
- Saeed, Bilal, MD
- Iturbe, Jose Miguel, MD, BA
- Shunk, Kendrick, MD, PhD
- Bissett, Joseph K., MD
- Sachdeva, Rajesh, MD
- Voudris, Vassilios V., MD, PhD
- Karyofillis, Panagiotis, MD
- Kar, Biswajit, MD
- Rossen, James, MD
- Fasseas, Panayotis, MD
- Berger, Peter, MD
- Banerjee, Subhash, MD
- Brilakis, Emmanouil S., MD, PhD
2009
Details
- Autor(en) / Beteiligte
- Lichtenwalter, Christopher, MD
- de Lemos, James A., MD
- Roesle, Michele, RN
- Obel, Owen, MD
- Holper, Elizabeth M., MD
- Haagen, Donald, RCIS
- Saeed, Bilal, MD
- Iturbe, Jose Miguel, MD, BA
- Shunk, Kendrick, MD, PhD
- Bissett, Joseph K., MD
- Sachdeva, Rajesh, MD
- Voudris, Vassilios V., MD, PhD
- Karyofillis, Panagiotis, MD
- Kar, Biswajit, MD
- Rossen, James, MD
- Fasseas, Panayotis, MD
- Berger, Peter, MD
- Banerjee, Subhash, MD
- Brilakis, Emmanouil S., MD, PhD
- Titel
- Clinical Presentation and Angiographic Characteristics of Saphenous Vein Graft Failure After Stenting
- Ist Teil von
- JACC. Cardiovascular interventions, 2009-09, Vol.2 (9), p.855-860
- Ort / Verlag
- Elsevier Inc
- Erscheinungsjahr
- 2009
- Link zum Volltext
- Quelle
- EZB Electronic Journals Library
- Beschreibungen/Notizen
- Clinical Presentation and Angiographic Characteristics of Saphenous Vein Graft Failure After Stenting: Insights From the SOS (Stenting Of Saphenous Vein Grafts) Trial Christopher Lichtenwalter, James A. de Lemos, Michele Roesle, Owen Obel, Elizabeth M. Holper, Donald Haagen, Bilal Saeed, Jose Miguel Iturbe, Kendrick Shunk, Joseph K. Bissett, Rajesh Sachdeva, Vassilios V. Voudris, Panagiotis Karyofillis, Biswajit Kar, James Rossen, Panayotis Fasseas, Peter Berger, Subhash Banerjee, Emmanouil S. Brilakis Among patients undergoing saphenous vein graft (SVG) stenting in the SOS (Stenting Of Saphenous Vein Grafts) trial, SVG occlusion occurred in 43% and 50% of failed SVGs in the bare-metal stent (BMS) group and the drug-eluting stent group, respectively. SVG failure after stenting presented as acute coronary syndrome in 10 of 24 patients (42%). Of 19 patients (with 20 grafts) who developed symptomatic graft failure, repeat SVG revascularization was successfully performed in all 13 (100%) subtotally obstructed SVGs versus in 1 of 7 (14%) occluded SVGs. SVG failure after stenting often presents as acute myocardial infarction and with SVG occlusion. Compared with BMS, paclitaxel-eluting stents reduce SVG failure.
- Sprache
- Englisch
- Identifikatoren
- ISSN: 1936-8798eISSN: 1876-7605DOI: 10.1016/j.jcin.2009.06.014Titel-ID: cdi_crossref_primary_10_1016_j_jcin_2009_06_014